Literature DB >> 27506915

[Individualized treatment of colon cancer].

Andreas Weinberger Rosen1, Thea Helene Degett, Ismail Gögenur.   

Abstract

The treatment of colon cancer has undergone a rapid development with improved surgical and medical regimes and the introduction of targeted treatments. This review offers insight into the current available tailored treatment of colon cancer, and some of the new tailored treatment possibilities with focus on preoperative-, surgical- and post-operative treatment are presented.

Entities:  

Mesh：

Year:  2016        PMID： 27506915

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN： 0041-5782


  8 in total

1.  miR-23b-3p Inhibits the Oncogenicity of Colon Adenocarcinoma by Directly Targeting NFE2L3.

Authors:  Guohong Huang; Yimei Yang; Mengxin Lv; Tian Huang; Xiaoyan Zhan; Yingjie Yao; Jianghou Hou
Journal:  J Oncol       Date:  2021-12-20       Impact factor: 4.375

2.  Effect of miR-488 on Colon Cancer Biology and Clinical Applications.

Authors:  Liangqin Wu; Songguo Li; Peng Shu; Qian Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-05       Impact factor: 2.650

3.  DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer.

Authors:  Mengna Zhang; Yanan Peng; Zhenwei Yang; Hailin Zhang; Cong Xu; Lan Liu; Qiu Zhao; Jixiong Wu; Hongling Wang; Jing Liu
Journal:  BMC Cancer       Date:  2022-05-19       Impact factor: 4.638

4.  Autophagy-related genes contribute to malignant progression and have a clinical prognostic impact in colon adenocarcinoma.

Authors:  Xianyi Zhang; Runtao Xu; Wenjing Feng; Jiapeng Xu; Yulong Liang; Jinghui Mu
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

5.  Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway.

Authors:  Qin Li; Yan Ma; Xiao-Lu Liu; Li Mu; Bai-Cheng He; Ke Wu; Wen-Juan Sun
Journal:  Oncol Rep       Date:  2020-08-28       Impact factor: 3.906

6.  Long Non-Coding RNA ELFN1-AS1 Promoted Colon Cancer Cell Growth and Migration via the miR-191-5p/Special AT-Rich Sequence-Binding Protein 1 Axis.

Authors:  Yongjun Du; Yanmei Hou; Yongbo Shi; Juan Liu; Tingxin Li
Journal:  Front Oncol       Date:  2021-02-09       Impact factor: 6.244

7.  LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway.

Authors:  Ding Li; Ding Wang; Haofeng Liu; Xiaohui Jiang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

8.  Six Genes Associated with Lymphatic Metastasis in Colon Adenocarcinoma Linked to Prognostic Value and Tumor Immune Cell Infiltration.

Authors:  Baoquan Wang; Changjun Yin; Xu Yang; Huibo Shi; Zheng Zhang; Jun Zhou; Peitong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-29       Impact factor: 2.650
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.